These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 25468285)

  • 1. Pleiotropy in aggressive prostate cancer?
    Cox A
    Eur Urol; 2015 Apr; 67(4):658-9. PubMed ID: 25468285
    [No Abstract]   [Full Text] [Related]  

  • 2. A genome-wide pleiotropy scan for prostate cancer risk.
    Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
    Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population.
    Rădăvoi GD; Pricop C; Jinga V; Mateş D; Rădoi VE; Jinga M; Ursu RI; Bratu OG; Mischianu DL; Iordache P
    Rom J Morphol Embryol; 2016; 57(2):467-75. PubMed ID: 27516020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of genome-wide and replication association studies on prostate cancer.
    Liu H; Wang B; Han C
    Prostate; 2011 Feb; 71(2):209-24. PubMed ID: 20690139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genome-wide association study(GWAS) and genetic risk of prostate cancer].
    Nakagawa H; Akamatsu S; Takata R
    Nihon Rinsho; 2016 Jan; 74(1):34-9. PubMed ID: 26793876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical uncertainty of prostate cancer genetic risk panels.
    Pomerantz M; Freedman ML
    Sci Transl Med; 2013 Apr; 5(182):182ed6. PubMed ID: 23616119
    [No Abstract]   [Full Text] [Related]  

  • 7. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
    Helfand BT; Hu Q; Loeb S; McVary KT; Catalona WJ
    J Urol; 2013 Mar; 189(3):845-8. PubMed ID: 23159463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer Risk Loci Are Associated with Gene Regulatory Mechanisms.
    Cancer Discov; 2016 May; 6(5):OF13. PubMed ID: 26988667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary link: scientists seek clues in genetic risks for prostate cancer.
    Printz C
    Cancer; 2014 Dec; 120(24):3847-8. PubMed ID: 25474225
    [No Abstract]   [Full Text] [Related]  

  • 11. Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.
    Goh CL; Eeles RA
    Recent Results Cancer Res; 2014; 202():9-26. PubMed ID: 24531773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer: plasma whole-genome sequencing put to the test.
    Razzak M
    Nat Rev Urol; 2013 Jun; 10(6):309. PubMed ID: 23609846
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics of prostate cancer risk.
    Pomerantz MM; Freedman ML
    Mt Sinai J Med; 2010; 77(6):643-54. PubMed ID: 21105126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Genome-Wide Association Study of Prostate-Specific Antigen Levels Identifies Novel Loci Independent of Prostate Cancer.
    Atala A
    J Urol; 2017 Oct; 198(4):747. PubMed ID: 28905792
    [No Abstract]   [Full Text] [Related]  

  • 15. Genome-wide association studies provoke debate and a new look at strategy.
    Tuma RS
    J Natl Cancer Inst; 2009 Aug; 101(15):1041-3. PubMed ID: 19638504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic predisposition to prostate cancer].
    Jeanteur P
    Bull Cancer; 2008 Nov; 95(11):1063-6. PubMed ID: 19036678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
    Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
    J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
    Shen J; Li Z; Song Z; Chen J; Shi Y
    Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma.
    Chen X; McClelland M; Jia Z; Rahmatpanah FB; Sawyers A; Trent J; Duggan D; Mercola D
    Oncotarget; 2015 Jan; 6(3):1865-73. PubMed ID: 25638161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.